SCHEMBL25980248

SCHEMBL25980248

COC(=O)c1ccc(CCCCc2cccc(F)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 4/20 0.61
CYP4F2 P78329 3/20 0.61
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
MAPT P10636 2/20 0.53
MRGPRX4 Q96LA9 1/20 0.53
LOXL2 Q9Y4K0 1/20 0.51
IDH1 O75874 1/20 0.48
CCR6 P51684 1/20 0.48
HKDC1 Q2TB90 1/20 0.48
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
LMNA P02545 2/20 0.47
TP53 P04637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20608510 0.99 CYP4A11 (0.60) CYP4A11CYP4F2KMT2AMEN1NPC1
Hydrochloric Acid SCHEMBL16506853 0.86 MEN1 (0.50) CYP4A11CYP4F2KMT2AMEN1NPC1
SCHEMBL9938980 0.85 KMT2A (0.56) CYP4A11CYP4F2KMT2AMEN1NPC1
SCHEMBL16709809 0.83 SMN1; SMN2 (0.54) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL2404460 0.82 CYP4A11 (0.73) CYP4A11CYP4F2NPC1RAB9AMAPT
SCHEMBL25980172 0.81 CYP4A11 (0.58) CYP4A11CYP4F2KMT2AMEN1NPC1
SCHEMBL14966467 0.80 MRGPRX4 (0.63) CYP4A11CYP4F2KMT2AMEN1NPC1
SCHEMBL2196098 0.79 MAOB (0.75) MRGPRX4MAOB
SCHEMBL8755066 0.79 CA1 (0.69) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL25980198 0.79 CYP4A11 (0.60) CYP4A11CYP4F2KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248735-A1 COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248735-A1 COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) NR1H2, CFTR, CYP11B2 CYP4A11 69/4885CYP4F2 1384/4885KMT2A 4539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.